@article{ref1,
title="Rimonabant, suicide and depression: Depression and suicidal tendencies are about twice as frequent with rimonabant as with placebo",
journal="Prescrire International",
year="2007",
author="",
volume="16",
number="92",
pages="250-250",
abstract="Rimonabant is anorectic anti-obesity drug. It is a selective cannabinoid receptor (CB1) blocker. It is also being evaluated as an aid in smoking cessation and to help prevent weight gain in former smokers.  <p>Language: en</p>",
language="en",
issn="1167-7422",
doi="",
url="http://dx.doi.org/"
}